The Maternal Spindle Transfer clinical study commenced in 2015, in partnership with Embryotools, and consisted of 3 phases:

Phase 1 was the preclinical trial on murinae. This preclinical trial was awarded by the American Society for Reproductive Medicine (ASRM).

Phase 2 involved the preclinical trial on human oocytes.

Phase 3, which was the final stage of the clinical study, involved a pilot clinical trial leading to pregnancy.

As part of this pilot trial, five healthy babies have been born by women who had experienced multiple failed IVF attempts. The babies are monitored based on a special pediatric protocol and are all in excellent health.

In January 2020, the Institute of Life scientific team received an award from the Athens Chamber of Commerce and Industry (ACCI). Specifically, the scientific team received the Research, Innovation & Technological Advancement Award for its Maternal Spindle Transfer clinical study.

Important Note:

Births of children using the maternal spindle transfer method are performed in the context of an ongoing research protocol concerning a pilot trial that leads to pregnancy, which is conducted in accordance with the terms and conditions of Law 3305/2005. Based on current scientific findings, the maternal spindle transfer method is not an established infertility treatment, nor a recognized method of medically assisted reproduction.